Asan Multivessel Registry
ASAN MV
Asan Medical Center Registry for Multivessel
1 other identifier
observational
25,000
1 country
1
Brief Summary
The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2014
CompletedFirst Posted
Study publicly available on registry
January 20, 2014
CompletedStudy Start
First participant enrolled
March 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
January 2, 2026
December 1, 2025
16.3 years
January 14, 2014
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
composite event
death, myocardial infarction, stroke, revascularization
1year
Secondary Outcomes (8)
Death
1year
Myocardial Infarction
1year
Stroke
1year
Revascularization
1year
Angina symptom
1year
- +3 more secondary outcomes
Study Arms (1)
Multivessel
from 1995
Interventions
Eligibility Criteria
Patients with multivessel disease from 1995 in Asan Medical Center
You may qualify if:
- Patients with multivessel disease from 1995 in Asan Medical Center
- Age 19 and more
You may not qualify if:
- For prospective cohort, not agreeing to participate with written informed consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seung-Jung Parklead
- CardioVascular Research Foundation, Koreacollaborator
Study Sites (1)
Asan Medical Center
Seoul, South Korea
Related Publications (3)
Park J, Kim SH, Kim M, Lee J, Choi Y, Kim H, Kim TO, Kang DY, Ahn JM, Yoo JS, Kim HJ, Kim JB, Choo SJ, Chung CH, Park SJ, Park DW; Asan-Multivessel Registry Investigators. Impact of Optimal Medical Therapy on Long-Term Outcomes After Myocardial Revascularization for Multivessel Coronary Disease. Am J Cardiol. 2023 Sep 15;203:81-91. doi: 10.1016/j.amjcard.2023.06.083. Epub 2023 Jul 21.
PMID: 37481816DERIVEDKim TO, Kang DY, Ahn JM, Kim SO, Lee PH, Lee J, Kim JH, Kim HJ, Kim JB, Choo SJ, Chung CH, Lee JW, Park SJ, Park DW; Asan Medical Center-Multivessel Revascularization Registry Investigators. Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization. J Am Coll Cardiol. 2022 Apr 5;79(13):1270-1284. doi: 10.1016/j.jacc.2022.01.035.
PMID: 35361350DERIVEDKim TO, Ahn JM, Kang DY, Park H, Kim SO, Lee PH, Lee J, Kim JH, Jeong YJ, Yang Y, Hyun J, Kim HJ, Kim JB, Choo SJ, Chung CH, Lee JW, Park SJ, Park DW; Asan-Multivessel Registry Investigators. Long-Term Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents or Coronary Artery Bypass Grafting for Multivessel Coronary Disease. Am J Cardiol. 2021 Dec 1;160:21-30. doi: 10.1016/j.amjcard.2021.08.047. Epub 2021 Oct 3.
PMID: 34610874DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD,PhD
Study Record Dates
First Submitted
January 14, 2014
First Posted
January 20, 2014
Study Start
March 1, 2014
Primary Completion (Estimated)
June 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
January 2, 2026
Record last verified: 2025-12